News Releases 2017

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Keyword Search
Search by Year
05/16/17Charles River Laboratories Announces Updates to Oncology BusinessPrinter Friendly Version
05/10/17Charles River Laboratories Announces First-Quarter 2017 Results from Continuing OperationsPrinter Friendly Version
04/12/17Charles River Laboratories Schedules First-Quarter 2017 Earnings Release and Conference CallPrinter Friendly Version
04/05/17Nimbus Therapeutics Enters into Strategic Partnership with Charles River Laboratories to Advance New Therapeutic ProgramsPrinter Friendly Version
04/03/17Charles River Laboratories Announces Launch of Triple-Immunodeficient Mouse Model for Oncology ResearchPrinter Friendly Version
03/13/17Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery ProgramPrinter Friendly Version
03/06/17Charles River Laboratories to Present at Raymond James and Barclays ConferencesPrinter Friendly Version
02/14/17Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 GuidancePrinter Friendly Version
02/09/17Charles River Laboratories Changes Time of Fourth-Quarter 2016 Earnings and 2017 Guidance Conference CallPrinter Friendly Version
01/30/17Charles River Laboratories Announces Progress Update for Collaboration with Moderna TherapeuticsPrinter Friendly Version
01/19/17Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings and 2017 Guidance Release and Conference CallPrinter Friendly Version
01/09/17Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version